Dermatology

COVID-19 disrupted melanoma diagnoses, reducing early detection and shifting prognostic patterns across regions with different public health strategies.

Narrowband and broadband UVB show similar efficacy in atopic dermatitis, but narrowband therapy is better tolerated, a randomised trial finds.

The systemic effects of sunlight may include lower mortality and reduced disease burden, according to a decade-long review.

Ultrasound and CT improve nodal staging in high-risk cSCC but show reduced accuracy in immunosuppressed patients. Learn more about diagnostic strategies.

New research identifies PA2G4 as a key driver of keratinocyte proliferation and survival in psoriasis, offering a potential new therapeutic target.

Pirfenidone exosomes improve wound healing and reduce scarring in preclinical models. Discover this innovative antifibrotic therapy. Read more.

A Japanese study highlights poorer outcomes in paranasal mucosal melanoma and identifies neutrophil–lymphocyte ratio as a key prognostic biomarker.

A major cohort study finds no meaningful link between atopic dermatitis and poorer academic performance in adolescents.

Dupilumab significantly improves disease severity and lesion healing in prurigo nodularis, according to pooled Phase III trial data.

Study introduces a clinical score to predict laryngeal involvement in pemphigus vulgaris, supporting targeted use of laryngoscopy.

Patients with chronic lymphocytic leukemia face nearly double the risk of skin cancer, with increased metastasis and mortality, a large cohort study finds.

A European study shows photopatch testing with longer occlusion improves detection of sunscreen and NSAID photoallergies.

Meta-analysis shows AI-assisted melanoma diagnosis performs similarly to dermatologists, though further validation is needed for routine clinical use.

A real-world study shows delgocitinib matches PUVA effectiveness in chronic hand eczema, with trends toward improved quality of life.

Longer antibiotic courses for acne raise recurrence and resistance risk without improving short-term outcomes, new real-world data show.

A phase 2 trial shows promising results for hidradenitis suppurativa treatment, offering hope for patients with limited options after anti TNF therapy failure.

Liposomal retinol and niacinamide improve stability, skin penetration, and anti-aging effects, offering promise for advanced skincare formulations.

Patients with rosacea may face a higher risk of depression, according to a large Korean cohort study highlighting the need for integrated care.

The MEL-SELF trial reveals gaps in melanoma self-examination practices, highlighting patient confidence and psychological factors affecting early detection.

LAG-3 and TIGIT expression may predict skin melanoma progression and survival. Discover how these immune markers could shape future therapies. Read more.

Most early responders with atopic dermatitis sustain minimal disease activity at one year, with baseline factors predicting long-term control.

Three-year BE RADIANT results highlight durable bimekizumab benefits in plaque psoriasis, improving PROs and QoL. Read more.

A randomised placebo-controlled study shows silicone gel significantly improves scar quality in head and neck wounds without adverse effects.

Major depressive disorder shares a Th2 immune signature with atopic dermatitis, highlighting dupilumab as a potential targeted therapy.

A long-term cohort study shows molecular diagnostics can distinguish hand eczema from psoriasis, improving treatment decisions and patient quality of life.

Stopping washcloth use during bathing may significantly reduce chronic itch, according to a new observational dermatology study exploring simple lifestyle changes.

A study of nearly 12,000 adults links sedentary behaviour, late sleep and psychological distress to higher adult acne risk, while regular exercise shows protective benefits.

New research identifies a tRNA-derived RNA fragment that protects skin from UV-induced photoageing by preserving collagen and stabilising key mRNAs.

Global analysis finds people with atopic dermatitis have significantly higher rates of asthma and rhinitis, highlighting the need for integrated respiratory screening.

Sunscreen use may prevent UV-induced gene and epigenetic changes, helping maintain pathways linked to healthy skin, according to new molecular profiling research.

A phase IIb trial demonstrates that topical pumecitinib 3% gel significantly improves mild-to-moderate atopic dermatitis, with twice-daily dosing showing superior efficacy.

A cohort study shows mycophenolate mofetil and methotrexate reduce disease activity in juvenile localised scleroderma, with fewer adverse effects seen with MMF.

A 52-week study shows risankizumab improves both visible psoriasis and underlying vascular inflammation, with OCT revealing sustained subclinical skin changes.

A nationwide Dutch study reports treatment patterns, upstaging rates, and long-term recurrence outcomes in patients with lentigo maligna.

Acne risk rises sharply in transmasculine individuals starting testosterone and also affects transfeminine patients on estradiol. Read more.

Real-world data from Italy show high two-year drug survival and sustained disease control with bimekizumab in moderate-to-severe plaque psoriasis.

A birth cohort study reveals how genetics, environment, and hygiene shape the infant skin microbiome and its early links to atopic dermatitis.

Real-world registry data from Germany show apremilast improves psoriasis severity and quality of life, with a safety profile consistent with clinical trials.

Real-world data suggest lebrikizumab delivers sustained clinical and quality-of-life improvements in patients with moderate-to-severe atopic dermatitis.

Lower dietary antioxidant intake is linked to higher oxidative stress in rosacea, with potential implications for disease severity and clinical management.

Real-world Danish registry data show that biologic drug survival in psoriasis differs between biologic-naive and bioexperienced patients.

Adjunctive vitamin D may improve pain, healing, and inflammation in oral lichen planus, with benefits most evident during the first six weeks of treatment.

Spatial proteomics analysis shows tertiary lymphoid structures correlate with immunotherapy response and survival in Merkel cell carcinoma.

A large Mendelian randomisation study reveals that higher BMI and IBD causally increase hidradenitis suppurativa risk, providing actionable insights for dermatologists and patient counselling.

Adjunctive NB-UVB phototherapy improved disease control in chronic plaque psoriasis patients with secondary loss of response to adalimumab.

Genetic analysis shows higher BMI increases hidradenitis suppurativa risk, while smoking evidence is inconclusive. The study also supports a causal link with IBD.

Vixarelimab significantly reduced itch severity and improved skin clearance in patients with prurigo nodularis in a phase 2b randomized clinical trial.

New epidemiological data reveal long serial intervals and sustained scabies transmission in Europe, highlighting how modest prevention could curb epidemic growth.

High-throughput proteomics identifies inflammatory clusters and biomarkers associated with disease severity and treatment response in bullous pemphigoid.

A Pan-European study reports high rates of addictive behaviours among patients with chronic skin diseases, linked to poorer quality of life and key demographic factors.

Most systemic therapy-naïve patients with moderate-to-severe atopic dermatitis or psoriasis in Germany wish to escalate treatment, with clear preferences for administration route.

A large, multiethnic study reveals distinct facial microbiota patterns in adolescents with acne, identifying key bacterial species linked to acne pathology.

A new Nordic study reports no clear increase in major congenital malformations among infants exposed to topical retinoids in early pregnancy.

New research shows metabolic liver disease is linked to increased androgenetic alopecia risk, with stronger effects in women and those with unhealthy lifestyle patterns.

Fibroblasts fuel skin and systemic inflammation via a CXCL10–glycolysis axis in dermatomyositis, offering new metabolic treatment opportunities.

A phase 3 trial shows dupilumab significantly improves quality of life in omalizumab-naïve patients with chronic spontaneous urticaria.

IMCAS World Congress 2026 unites global dermatology experts to explore advances in science, aesthetics, and complication management across lasers, dermatology, and injectables.

New phase 3 trial finds ivarmacitinib ointment provides rapid, lasting relief from mild-to-moderate eczema with a favourable safety profile.

A large retrospective study shows JAK2 gene fusion occurs in both aggressive and indolent cutaneous T-cell lymphomas, offering new insight into diagnosis and targeted treatment.

Swedish study shows patients with stage IIC melanoma have poorer survival than stage IIIA, highlighting need for closer follow-up and treatment.

A phase 1b/2a trial reports that stapokibart is well tolerated and improves symptoms in children aged 6–11 years with moderate-to-severe atopic dermatitis.

A new trial finds maternal prebiotic supplementation during pregnancy does not prevent atopic dermatitis in high-risk infants at one year of age.

Lupus-like disease linked to MDS/CMML shows distinct features and poor response to standard treatment, improving with clone-directed therapy.

GLP-1 agonists are more often prescribed for hidradenitis suppurativa patients with obesity, diabetes, and other metabolic conditions.

A study shows adding oral ivermectin to permethrin improves cure rates and speeds symptom relief in children with persistent scabies, with regular follow-up over several months.

Survivors of SJS/TEN report lasting physical, psychological, and social effects, with major gaps in post-discharge care and support highlighted in a new qualitative study.

Researchers demonstrate how cross-modal imaging can noninvasively identify histologic features of skin, advancing precision in dermatologic diagnosis.

A major cohort study involving over 20 million patients found that seborrheic dermatitis was significantly associated with several epithelial barrier diseases.

A UK online trial found that daily and weekly bathing make no difference to eczema symptoms.

Recent research has demonstrated that copy-number variants play a central role in acquired ICI resistance.

Recent research has highlighted the potential of barzolvolimab, a first-in-class monoclonal antibody developed to inhibit the KIT receptor.

The relationship between physical activity and psychological wellbeing in vitiligo has gained attention in recent years.

A new study identifies active rash, interstitial lung disease, and elevated neutrophil-to-lymphocyte ratio as key predictors of in-hospital death among patients with dermatomyositis.

Recent research highlights programmed cell death mechanisms, apoptosis and necroptosis, as central to Stevens-Johnson syndrome and toxic epidermal necrolysis pathology.

Overall, the research suggests that incorporating T-cell receptor clonotype biomarkers into routine clinical assessment could significantly enhance risk stratification.

Diabetes and psoriasis together increase risk of all-cause and cancer mortality, according to a U.S. population study.

Social appearance anxiety was strongly linked to higher general anxiety, depressive symptoms, and reduced quality of life.

Discover a study showing how hydrocolloid dressing provides scar appearance comparable to daily petroleum ointment, with improved comfort and convenience for patients.

This new study examined whether stressful life factors in early childhood increase the likelihood of developing psoriasis later in life.

Crucially, most of the TFS period with the combination therapy was spent without severe toxicity, reflecting an improved quality of life.

This finding highlights that even small differences may have meaningful public health implications, given the high global prevalence of AD.

The results demonstrated a measurable improvement in acne lesion counts and significant shifts in the skin microbiota.

Many participants reported that a lack of understanding about skin cancer symptoms led to delays in seeking medical help.

A risk-stratified approach significantly enhanced skin cancer detection after organ transplantation without increasing health care burden.

In a single-centre, randomised, double-blind, sham-controlled clinical trial, 72 patients with ETR were enrolled to assess the efficacy of taVNS compared with sham stimulation.

AI tools achieve high accuracy diagnosing both STIs and anogenital dermatoses from clinical images, but more validation is needed.

Discover a study revealing how the seboselective 1726-nm laser delivers safe, long-lasting acne treatment results with improved skin clarity and confidence.

Discover a study on oral povorcitinib for vitiligo, showing significant repigmentation and safety in patients with extensive nonsegmental vitiligo.

A recent post hoc analysis used data from a Phase III trial of the new interleukin (IL)-17A inhibitor, vunakizumab, to explore predictors of early response.

Skin-to-skin contact in hospital helps very preterm infants develop stronger brain pathways for stress and emotions.

The International Psoriasis Council (IPC) has outlined clear criteria to help clinicians determine when systemic therapy should be prioritised.

Discover a study showing how neoadjuvant immunotherapy with tiragolumab and atezolizumab improves response rates and safety in high-risk Stage III melanoma.

In a randomised, placebo-controlled trial, researchers evaluated VC-H1, a hibiscus enzyme extract, as an oral plant-based collagen alternative for photoaged skin.

The study demonstrated that [99mTc]Tc-Tilmanocept could detect secondary lesions in patients with melanoma undergoing ICI treatment.

Discover a study exploring how hyaluronic acid and amino acids work together to accelerate healing in hard-to-heal wounds.

Oral isotretinoin remains the most effective therapy, although its precise mechanism is not fully understood.

Patients receiving once-daily upadacitinib 30 mg achieved significantly greater reductions in abscesses and inflammatory nodules compared with historical placebo rates.

The results revealed that patients with AD displayed a less favourable cardiovascular risk profile.

Beyond disease associations, CPAP mask-related skin complications such as dermatitis may arise due to friction, pressure, moisture, or sensitivity to mask materials.

A key finding was that patients treated at specialist centres experienced a significantly shorter delay in switching from immunosuppressants to advanced systemic therapies.

In Cohort 1, data from 787 participants revealed that current smokers, who comprised 53.9% of the group, were more likely to present with severe disease.

Discover a study linking select autoimmune diseases with increased risks of melanoma and non-melanoma skin cancers, highlighting the need for closer surveillance.

Importantly, patients with clear margins from excisional biopsy alone, who did not undergo wide excision, showed no recurrence after a median of more than eight years.

Ultraviolet B (UVB) phototherapy is the traditional non-pharmacological approach, promoting repigmentation by stimulating melanin production.

Global prevalence of HS, estimated between 0.67–1.46%, surpassed previous estimates, with substantial global variations.

While medical treatments remain the cornerstone of care, skincare is increasingly being recognised as a valuable adjunct to therapy.

Learn how AI-driven skincare improved acne and quality of life more effectively than self-chosen products in recent clinical trial.

Discover a study evaluating combined dye and alexandrite laser therapy, offering promising results for improving outcomes in patients with papulopustular rosacea.

The study found that almost 8% of individuals aged two years and above had asthma, while more than half (52.3%) reported allergy symptoms.

Objective biometric measures showed improvement in both groups, but the combination therapy produced significantly greater benefits.

Clinical examination is limited by visual similarity between benign and malignant lesions and imperfect diagnostic accuracy.

Delgocitinib ointment could be an effective and safe option for patients with face or neck atopic dermatitis (AD) who are concerned about the side effects of topical steroids or tacrolimus

Biomarker analyses continue to provide insights but have not yet established clear rules for patient selection.

By Month 6 (M6), 50–60% achieved at least a one-point improvement across validated HS severity measures.

Discover a study comparing intralesional triamcinolone and methotrexate for alopecia areata, revealing superior regrowth and patient satisfaction with triamcinolone.

This study evaluated the psychometric performance and interpretability of HiSQOL using data from two multinational Phase III trials of bimekizumab in moderate-to-severe HS.

A recent study evaluated a novel 2% salicylic acid gel enriched with hydrating and soothing agents, aiming to balance acne treatment with skin barrier repair.

Apremilast shows sustained 52-week efficacy and safety in children with moderate to severe plaque psoriasis.

Discover how fewer melanoma cases with more severe features were seen during COVID, highlighting need for robust skin cancer pathways.

Biologic switching in psoriasis improves skin outcomes but requires careful infection monitoring, finds major review.

Patients with hidradenitis suppurativa face a significantly higher risk of developing new-onset depression and anxiety, according to a large Danish population-based study.

Daily moisturising may prevent infant eczema, even in low-risk babies, offering a practical approach for early skin care.

Discover a study highlighting the improved effectiveness of combining light-based therapy with tranexamic acid for treating facial redness.

Results showed the secretome-HA sponge improved skin hydration, reduced transepidermal water loss, increased skin elasticity.

Results from the 12-month double-blind, placebo-controlled trial revealed that the vaccinated group consistently experienced greater reductions in AK lesions than the control group.

The study examined flare patterns reported in 2022 and correlated them with patient-reported severity measures recorded in 2023.

These vaccines work by activating the immune system to recognise and attack tumour cells, while also creating immune memory for long-term protection.

Results demonstrated a clear association between elevated emotional distress and poorer TIL therapy outcomes.

Gene expression analysis also revealed that increased Myc-related gene expression correlated with poorer outcomes.

Discover a study highlighting how tapinarof cream 1% delivers rapid, clinically significant itch relief in children and adults with atopic dermatitis.

Both treatments resulted in significant improvement in inflammatory acne lesions; however, IPL yielded better overall outcomes.

This post hoc analysis included data from 25 randomised clinical trials, assessing over five years of IXE exposure in patients with psoriasis.

As HS remains underdiagnosed and undertreated, findings such as these could help support more informed, patient-specific therapeutic decisions moving forward.

A recent study has demonstrated that deep learning models can enhance diagnostic accuracy in differentiating these pigmented lesions.

Discover a study revealing how vitamin C supports skin regeneration by promoting keratinocyte proliferation through epigenetic DNA demethylation.

The study highlights how HR pathway alterations, which affect roughly a fifth to a third of melanomas, may offer an opportunity for targeted treatment.

VISIBLE Cohort B represents a landmark study in psoriasis research, being the only scalp psoriasis trial exclusively including individuals with skin of colour.

Researchers developed a self-injection assistance device, allowing patients to administer triamcinolone themselves under medical guidance.

Given dupilumab’s well-documented benefits in controlling moderate to severe AD, clinicians are advised to weigh this potential risk carefully against its therapeutic advantages.

The bidirectional relationship between psoriasis and MetS was supported by evidence showing that metabolic disturbances can also exacerbate psoriasis symptoms.

Discover a study where two investigators, using new TikTok accounts registered as 13-year-olds, collected and analysed the videos through the platform’s “For You” tab.

Following surgery, 97.2% of patients experienced a reduction in psoriasis severity to mild levels or complete resolution.

The findings indicate that children with HS are significantly more likely to suffer from a range of both physical and mental health conditions.

The model integrates four key types of imagery: total-body photographs, standard clinical photos, dermoscopic close-ups, and dermatopathology slides.

Compared to patients from the highest SES quintile, those in the lowest quintile had over three times the odds of being diagnosed with hidradenitis suppurativa.

A new global observational study has revealed a continued rise in skin cancer burden among older populations, particularly in high-income countries.

The results revealed that central adiposity, fat concentrated around the waist and abdomen, had the strongest link to psoriasis.

The findings highlight that abobotulinum toxin A and prabotulinum toxin A demonstrated the quickest onset of action.

In this study, researchers examined three international cohorts of patients with moderate-to-severe psoriasis undergoing biologic therapy.

Pure atopic dermatitis patients had a significantly higher prevalence of cardiovascular disease compared to those with atopic comorbidities

Young adults (18–29 years) had the highest UV exposure and sunburn rates, and were least likely to use protective clothing.

Interestingly, UVB exposure and topical application of cis-UCA led to changes in the skin’s microbial composition.

Mental health issues such as anxiety and depression are common comorbidities in people with atopic dermatitis.

The results demonstrated significantly greater improvement in the ivarmacitinib groups compared to placebo.

Discover a study that evaluated the effectiveness of hyperbaric oxygen therapy for radiation-induced dermatitis.

A study has shed new light on a novel approach to managing acne vulgaris, highlighting the efficacy of an oral nutraceutical.

Safety concerns surrounding certain therapies in children often lead to suboptimal management of atopic dermatitis.

Restoring the skin barrier is key in managing and potentially preventing atopic dermatitis.

An increasingly studied adjunctive therapy is Hyaluronic Acid, known for its hydrating, regenerative, and anti-inflammatory properties.

Beyond clinical outcomes, the simultaneous approach offered additional benefits: reduced overall treatment time and higher patient satisfaction.

This study underlines the urgent need for cost-conscious strategies in the management of plaque psoriasis.

Results revealed that the group using partially myristoylated carboxymethyl chitosan emulsion experienced a significantly greater reduction in EASI scores.

Discover a study with has highlighted the potential of a novel silk elastin-based sponge as an effective wound treatment.

A recent clinical trial has compared the effectiveness of IL-17 and IL-23 biologics in treating moderate to severe plaque psoriasis.

Discover a recent study that indicates that autonomous total body photography could be a valuable tool in dermatological settings.

The study’s findings suggest that targeting the epidermal innate immune system could improve long-term treatment outcomes.

Recent research has highlighted the role of neutrophil extracellular traps in inflammatory diseases.

The study assessed the risk of hospitalisation for serious infections based on different categories of systemic medications.

The results indicated that 3D total-body photography reduced the number of melanoma excisions compared to controls.

From a therapeutic perspective, these findings advocate for a more tailored approach to treatment.

Spesolimab, a monoclonal antibody targeting the interleukin (IL)-36 receptor, has been approved as the first GPP-specific therapy.

The findings of this study suggest that both 70% and 100% TCA achieve similar overall results.

Results suggest that standard HPV vaccination may offer a novel approach to actinic keratosis management.

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira.

A national cohort study found that veterans in the most disadvantaged areas had a higher risk of being diagnosed with thicker melanomas.

The study also highlighted the psychological burden of hyperhidrosis, linking the condition to increased anxiety, depression, and impaired quality of life.

A new study investigates the combination of nivolumab and hypofractionated radiotherapy in advanced melanoma.

Recent research highlights the role of gut microbiota in atopic dermatitis pathogenesis.

Although the Skindex-29 assessment indicated an improvement in emotional well-being after the first cycle, there were no significant or lasting changes.

The DermSat-7 is a self-administered instrument designed to evaluate patient satisfaction with psoriasis treatments over a 14-day recall period.

These findings highlight the effectiveness of low-dose oral minoxidil as an alternative to topical minoxidil.

This study aimed to compare the effects of antimicrobial–corticosteroid combination therapy with corticosteroid monotherapy.

The findings suggest that topical spironolactone 5% gel is an effective and well-tolerated treatment for acne vulgaris.

Findings suggest that probiotics’ ability to reduce the risk of atopic eczema may not depend on significant changes in gut microbiota.

Patients initially receiving placebo experienced notable improvement after switching to tildrakizumab.

Recent findings indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following treatment.

Leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

After five years, the probability of remaining free from treatment failure was 77.8% for patients who underwent superficial curettage.

While numerous pharmacological treatments for atopic dermatitis exist, there is a scarcity of effective nonpharmacological interventions.

A targeted rituximab infusion at 6 months, based on relapse predictors, significantly reduced pemphigus recurrence at one year.

Neoadjuvant T-VEC achieves resectability in 50% of difficult-to-treat BCC cases, improving outcomes without extensive reconstructive surgery.

Studies have shown that psoriasis patients exhibit elevated intestinal permeability, correlating with gastrointestinal discomfort.

Diabetes was investigated in five studies, with only one demonstrating a correlation between the condition and higher hospital readmission rates.

A recent study examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial alopecia, compared with matched healthy individuals.

A recent qualitative study has provided valuable insights into the experiences of Latine patients in the US living with moderate to severe psoriasis.

A gut-derived bacterial compound significantly slows vitiligo progression in mice, offering new hope for treatment and repigmentation.

Potent corticosteroids provide superior symptom relief for moderate atopic dermatitis flare-ups in children, enhancing primary care management.

This study aimed to evaluate whether novel biologics pose different risks of major adverse cardiovascular events compared with tumour necrosis factor inhibitors.

A recent multicentre, randomised clinical trial aimed to evaluate the efficacy and safety of combining baricitinib, with narrowband UV-B phototherapy in adults with severe, active, nonsegmental vitiligo.

Individuals with Down syndrome exhibit a hyperactive immune system marked by increased interferon signalling and cytokine production.

Recent research has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing scalp psoriasis.

A study leveraging social media platforms explored topical steroid withdrawal among individuals with atopic dermatitis.

The study revealed that 22.5% of patients experienced acne relapse, and 8.2% required isotretinoin retrial.

A comprehensive study of 2,657 patients assessed the relationship between chronic inflammatory disease comorbidities and alopecia areata characteristics.

Combining fractional CO2 laser with topical dutasteride improves androgenic alopecia outcomes compared to laser treatment alone.

The visible nature of dermatological symptoms exacerbates their impact, often leading to stigma, social withdrawal, and psychological distress, including anxiety and depression.

Genetic testing reveals key variants in palmoplantar keratoderma, aiding diagnosis and subtype differentiation.

COVID-19 increases the long-term risk of autoimmune disorders, especially in severe cases and unvaccinated individuals.

Cutaneous chronic graft-versus-host disease impairs quality of life, affecting social, psychological, physical functioning, and health perceptions.

Self-guided online CBT is noninferior to clinician-guided CBT for atopic dermatitis, offering effective and resource-efficient treatment.

Shared genetic, environmental, and microbial factors suggest a potential relationship between these diseases.

Given these results, patients with cutaneous lupus erythematosus may benefit from increased vigilance in cardiovascular screening and management.

Across both trial phases, adverse events were primarily mild to moderate, with no drug-related serious incidents reported.

The results suggest that while indoor tanning is a well-established risk factor for melanoma, it does not appear to contribute to tumour mutational burden in cutaneous melanoma tumours.

Improvement or stability of alopecia was observed in all patients after 3–6 months of low-dose oral minoxidil use.

Tapinarof cream 1%, a novel nonsteroidal aryl hydrocarbon receptor agonist, has emerged as a promising solution for plaque psoriasis.

A new study reveals that many acne-specific patient-reported outcome measures lack LGBTQ+-inclusive language, potentially undermining care for diverse patient populations.

Individuals with active psoriasis displayed a lower proportion of females and were more likely to be obese.

Low-dose oral minoxidil has emerged as a promising off-label treatment for hair loss.

Reflectance confocal microscopy is revolutionising dermatological imaging by providing non-invasive, detailed images of skin tissues.

Nutritional therapies, along with probiotic treatments, offer a holistic approach to managing these conditions by addressing both physiological and psychological symptoms.

Study reveals UV radiation and Merkel cell polyomavirus are major drivers of Merkel cell carcinoma in the US.

The study demonstrated that baricitinib significantly improved clinical signs of moderate-to-severe atopic dermatitis in children and adolescents at 16 weeks.

Rocatinlimab, a monoclonal antibody targeting the OX40 receptor on T cells, offers a novel approach to treating atopic dermatitis.

At week 16, dupilumab demonstrated significant benefits compared to placebo, regardless of the presence of asthma or AR.

Conditions such as cerebral infarction, acute myocardial infarction, pulmonary embolism, and venous thrombosis were more prevalent among those with vitiligo.

This study reinforces teledermoscopy’s utility for triaging skin lesions and prioritising high-risk cases for in-person care.

The findings suggest that healthcare systems must prioritise post-COVID-19 care, with a focus on identifying and managing autoimmune and autoinflammatory disorders.

A recent systematic review and meta-analysis reveals dermatologists have a significantly higher accuracy in diagnosing skin cancer

This study aimed to clarify the impact of COVID-19 infection and vaccination on the risk of developing autoimmune blistering diseases.

Patients with cancer treated with immune checkpoint inhibitors face a twofold increased risk of developing psoriasis

Treatments such as antioxidants, chemical peels, and laser therapy are available, but recent attention has turned to human platelet extract and vitamin C serums.

These findings confirm the usefulness of T-VASI and F-VASI in clinical trials, providing reliable thresholds for assessing the effectiveness of vitiligo treatments.

This regimen, including a treatment serum, a redness-reducing moisturiser, and sunscreen, showed promising results.

A recent study from 12 hospitals across China has shed new light on personalised care for plaque psoriasis.

New research finds that topical ferulic acid significantly improves skin lesions and barrier function.

The Royal College of General Practitioners (RCGP) has reported a significant rise in scabies cases presenting at GP surgeries across England…

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to improve management of this chronic condition.  

Home-based narrowband UV-B phototherapy for plaque or guttate psoriasis is just as effective as office-based treatment according to a recent randomised clinical trial.

A cohort study has examined whether an increased genetic risk of hidradenitis suppurativa is linked to a higher likelihood of developing cardiometabolic diseases.